Cefpodoxime proxetil is a third-generation cephalosporin antibiotic that works by interfering with the growth and division of bacteria, thus helping to control and eliminate the infection.
Clavulanic acid potassium is a beta-lactamase inhibitor that works by blocking enzymes produced by some bacteria that can break down certain antibiotics, making them ineffective. This helps to enhance the effectiveness of cefpodoxime proxetil against bacteria that produce beta-lactamase enzymes.
The combination of cefpodoxime proxetil and clavulanic acid potassium is often used to treat a range of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and genital infections.
The medication is available in tablet form and is taken orally. The dosage and duration of treatment may vary depending on the severity and type of infection, as well as the patient's age and medical history.
Like all antibiotics, cefpodoxime proxetil and clavulanic acid potassium can cause side effects, including gastrointestinal upset, diarrhea, nausea, vomiting, and allergic reactions. Serious side effects are rare but can occur, such as liver damage and blood disorders. It is essential to inform your doctor if you experience any of these symptoms while taking cefpodoxime proxetil and clavulanic acid potassium.
Cefpodoxime proxetil and clavulanic acid potassium can interact with other medications, including blood thinners and some antacids. It is important to inform your doctor of all medications you are taking before starting treatment with cefpodoxime proxetil and clavulanic acid potassium.